Literature DB >> 19955713

Intracranial hemorrhage in acute and chronic childhood immune thrombocytopenic purpura over a ten-year period: an Egyptian multicenter study.

Mohsen Elalfy1, Nancy Elbarbary, Normine Khaddah, Magy Abdelwahab, Farida El Rashidy, Hoda Hassab, Youssef Al-Tonbary.   

Abstract

Intracranial hemorrhage (ICH) is a rare but major cause of death in immune thrombocytopenic purpura (ITP). The authors reviewed data of 1,840 patient with ITP, from 5 pediatric hematology centers in Egypt from 1997 to 2007, to study the incidence and risk factors of ICH. Ten cases of ICH were identified with a median age at presentation of 7.5 years; 4 patients had acute ITP, 2 persistent and 4 chronic. The platelet count was <10 x 10(9)/l in 7 cases, and only 1 patient had a history of head trauma. Seven children were on treatment prior to or at the time of occurrence of ICH and all were treated by pharmacotherapy. Two children died shortly afterwards due to late referral to a specialized center. Our results suggest that treatment does not prevent ICH and that it can occur at any time during the course of the disease. Delayed referral can be considered a risk factor for unfavorable outcome of ICH, highlighting the importance of teaching sessions for patients and their parents to minimize subsequent morbidity and mortality of ICH in children with ITP. Copyright (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19955713     DOI: 10.1159/000262293

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  6 in total

Review 1.  Pediatric ITP: is it different from adult ITP?

Authors:  Jenny M Despotovic; Amanda B Grimes
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Updated international consensus report on the investigation and management of primary immune thrombocytopenia.

Authors:  Drew Provan; Donald M Arnold; James B Bussel; Beng H Chong; Nichola Cooper; Terry Gernsheimer; Waleed Ghanima; Bertrand Godeau; Tomás José González-López; John Grainger; Ming Hou; Caroline Kruse; Vickie McDonald; Marc Michel; Adrian C Newland; Sue Pavord; Francesco Rodeghiero; Marie Scully; Yoshiaki Tomiyama; Raymond S Wong; Francesco Zaja; David J Kuter
Journal:  Blood Adv       Date:  2019-11-26

3.  IVMP+IVIG raises platelet counts faster than IVIG alone: results of a randomized, blinded trial in childhood ITP.

Authors:  Manuel Carcao; Mariana Silva; Michele David; Robert J Klaassen; MacGregor Steele; Victoria Price; Cindy Wakefield; Lussia Kim; Derek Stephens; Victor S Blanchette
Journal:  Blood Adv       Date:  2020-04-14

4.  Spotlight on eltrombopag in pediatric ITP in China: a long-term observational study in real-world practice.

Authors:  Xiaoling Cheng; LingLing Fu; Jingyao Ma; Hao Gu; Zhenping Chen; Libo Zhao; Xiaoling Wang; Runhui Wu
Journal:  Blood Adv       Date:  2021-10-12

Review 5.  The Centenary of Immune Thrombocytopenia-Part 2: Revising Diagnostic and Therapeutic Approach.

Authors:  Rita Consolini; Giorgio Costagliola; Davide Spatafora
Journal:  Front Pediatr       Date:  2017-08-21       Impact factor: 3.418

6.  Therapeutic Suggestions for Chronic Subdural Hematoma Associated with Idiopathic Thrombocytopenic Purpura: A Case Report and Literature Review.

Authors:  Hajime Takase; Junya Tatezuki; Naoki Ikegaya; Daisuke Yamamoto; Mizuki Hashimoto; Makoto Takagi; Yasuhiko Mochimatsu; Nobutaka Kawahara
Journal:  NMC Case Rep J       Date:  2015-06-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.